The clinical characteristics of headache in patients with pituitary tumours

被引:204
作者
Levy, MJ
Matharu, MS
Meeran, K
Powell, M
Goadsby, PJ
机构
[1] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England
[3] Hammersmith Charing Cross Hosp Trust, Dept Endocrinol, London, England
基金
英国惠康基金;
关键词
pituitary tumour; headache; migraine; cluster headache;
D O I
10.1093/brain/awh525
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical characteristics of 84 patients with pituitary tumour who had troublesome headache were investigated. The patients presented with chronic (46%) and episodic (30%) migraine, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT; 5%), cluster headache (4%), hemicrania continua (1%) and primary stabbing headache (27%). It was not possible to classify the headache according to International Headache Society diagnostic criteria in six cases (7%). Cavernous sinus invasion was present in the minority of presentations (21%), but was present in two of three patients with cluster headache. SUNCT-like headache was only seen in patients with acromegaly and prolactinoma. Hypophysectomy improved headache in 49% and exacerbated headache in 15% of cases. Somatostatin analogues improved acromegaly-associated headache in 64% of cases, although rebound headache was described in three patients. Dopamine agonists improved headache in 25% and exacerbated headache in 21% of cases. In certain cases, severe exacerbations in headache were observed with dopamine agonists. Headache appears to be a significant problem in pituitary disease and is associated with a range of headache phenotypes. The presenting phenotype is likely to be governed by a combination of factors, including tumour activity, relationship to the cavernous sinus and patient predisposition to headache. A proposed modification of the current classification of pituitary-associated headache is given.
引用
收藏
页码:1921 / 1930
页数:10
相关论文
共 44 条
[21]   SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks [J].
Massiou, H ;
Launay, JM ;
Levy, C ;
El Amrani, M ;
Emperauger, B ;
Bousser, MG .
NEUROLOGY, 2002, 58 (11) :1698-1699
[22]   Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study [J].
Matharu, MS ;
Levy, MJ ;
Meeran, K ;
Goadsby, PJ .
ANNALS OF NEUROLOGY, 2004, 56 (04) :488-494
[23]  
May A, 1999, ANN NEUROL, V46, P791, DOI 10.1002/1531-8249(199911)46:5<791::AID-ANA18>3.0.CO
[24]  
2-8
[25]   OCTREOTIDE DEPENDENCY AND HEADACHE - A CASE-REPORT [J].
MAY, A ;
LEDERBOGEN, S ;
DIENER, HC .
CEPHALALGIA, 1994, 14 (04) :303-304
[26]   Hypothalamic activation in cluster headache attacks [J].
May, A ;
Bahra, A ;
Büchel, C ;
Frackowiak, RSJ ;
Goadsby, PJ .
LANCET, 1998, 352 (9124) :275-278
[27]   PET and MRA findings in cluster headache and MRA in experimental pain [J].
May, A ;
Bahra, A ;
Büchel, C ;
Frackowiak, RSJ ;
Goadsby, PJ .
NEUROLOGY, 2000, 55 (09) :1328-1335
[28]   Clusterlike headache in a patient with a pituitary adenoma. With a review of the literature [J].
Milos, P ;
Havelius, U ;
Hindfelt, B .
HEADACHE, 1996, 36 (03) :184-188
[29]   CLUSTER HEADACHE - EVIDENCE FOR A PATHOPHYSIOLOGIC FOCUS IN THE SUPERIOR PERICAROTID CAVERNOUS SINUS PLEXUS [J].
MOSKOWITZ, MA .
HEADACHE, 1988, 28 (09) :584-586
[30]  
Otsuka F, 1998, HEADACHE, V38, P629